Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits

• Jason M. Lempp,

  Current address: Qualis Health, Seattle, Washington, United States of America.

  Affiliations Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Margan J. Zajdowicz,

  Current address: Medical Corps, United States Navy, Bethesda, Maryland, United States of America.

  Affiliation Naval Hospital Great Lakes, Medical Corps, United States Navy, Great Lakes, Illinois, United States of America

  ⨯
• Arlene L. Hankinson,

  Current address: Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, New Jersey, United States of America.

  Affiliation Naval Hospital Great Lakes, Medical Corps, United States Navy, Great Lakes, Illinois, United States of America

  ⨯
• Sean R. Toney,

  Affiliation Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Lisa W. Keep,

  Current address: Medical Corps, United States Army, Bethesda, Maryland, United States of America.

  Affiliation Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Medical Corps, United States Army, Bethesda, Maryland, United States of America

  ⨯
• James D. Mancuso,

  Affiliation Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Medical Corps, United States Army, Bethesda, Maryland, United States of America

  ⨯
• Gerald H. Mazurek

  * E-mail: gym6@cdc.gov

  Affiliation Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  http://orcid.org/0000-0001-6142-1587

  ⨯